🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
using Atezolizumab, a PD-L1 inhibitor, in combination with bevacizumab, pla...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2020-04-10
Trial ID
NCT04147351
Treatments Being Tested
The goal of this study is to learn if people who receive intismeran autogen...
Status
Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0181)
Start Date
2024-10-21
Trial ID
NCT06623422
Treatments Being Tested
This is a multicenter, open Phase II clinical study to evaluate the efficac...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-08-28
Trial ID
NCT06514027
Treatments Being Tested
The primary objective of this study is to evaluate the objective response r...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-10
Trial ID
NCT07351565
Treatments Being Tested
This study is a multi-cohort, open-label, multi-center exploratory clinical...
Status
Not Yet Recruiting
Location
Shandong Cancer Hospital and Institute
Start Date
2024-10-10
Trial ID
NCT06649448
In this study circulating tumor DNA (ctDNA) blood testing is used to detect...
Status
Suspended
Location
Stanford University
Start Date
2021-04-08
Trial ID
NCT04585477
Phase Ib study to evaluate the tolerability, safety, pharmacokinetics and p...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-10-27
Trial ID
NCT07381829
Treatments Being Tested
This study is to assess the pharmacokinetics (PK) and safety of SC pembroli...
Status
Active Not Recruiting
Location
Fujita Health University ( Site 4406)
Start Date
2023-06-13
Trial ID
NCT06212752
The primary objectives of this study were: to assess the safety and tolerab...
Status
Completed
Location
Mayo Clinic Phoenix
Start Date
2019-08-15
Trial ID
NCT04047862
This study is a Phase III, international, multicenter, randomized, controll...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-09-26
Trial ID
NCT06970639